In breast cancer cell lines, elevated PrPc expression led to increased expression of MMP9 at both mRNA and protein levels through the activation of NF-κB and ERK pathways, contributing to the heightened motility of breast cancer cells [20]. This evidence concerns the gene NFKB1 and breast cancer.